Solesta Reimbursement Support Is Available Through Your Physician
Palette Life Sciences is committed to partnering with healthcare professionals to navigate insurance policies and optimize the cost of Solesta treatment.
Fecal incontinence treatment (Fit) study - now enrolling
Participants in the Fecal Incontinence Treatment (FIT) study will be assessed for reduction of fecal incontinence (FI) and randomized into three treatments arms: Behavioral: Biofeedback Procedure, Sacral Nerve Stimulation, or Device: Injection.
This Study is a collaboration between the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Mayo Clinic, Colon and Rectal Surgery Associates, Ltd., Augusta University, and RTI International. Palette Life sciences supports this study by providing Solesta without cost for the Device Study Arm.
Eligibility is solely determined by the FIT study investigator physicians.
Use our Find a Doctor tool to locate a bowel incontinence specialist near you.